During the past decade, Klinikum Obergöltzsch Rodewisch conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Obergöltzsch Rodewisch" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Spanish Breast Cancer Research Group (GEICAM)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Obergöltzsch Rodewisch" are "HER2-negative Breast Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Klinikum Obergöltzsch Rodewisch" in a lesser frequency.

Most popular intervention types in "Klinikum Obergöltzsch Rodewisch" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "Sacituzumab govitecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Obergöltzsch Rodewisch" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Obergöltzsch Rodewisch". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Klinikum Obergöltzsch Rodewisch, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Obergöltzsch Rodewisch, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".